The Effect of Gluten Free Diet on Components of Metabolic Syndrome: A Randomized Clinical Trial

Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2979-2984. doi: 10.22034/APJCP.2018.19.10.2979.

Abstract

Background: This study aimed to assess the effects of Gluten free diet (GFD) on components of metabolic syndrome (MES). Materials and Methods: In this randomized clinical trial, 50 subjects diagnosed with MES were randomly divided into two groups (n=25). The first group received a GFD and the second group continued their regular diet. Biochemical markers of MES and blood pressure were measured before and after 8-week intervention. Results: Forty five subjects completed the study. A post-hoc comparison of the groups showed no effects of the GFD and control diet on LDL cholesterol, total cholesterol, fasting insulin, HOMA-IR, systolic and diastolic blood pressure levels. The GFD reduced fasting blood glucose, waist circumference (WC) and serum triglyceride concentration significantly compared with the control diet (p<0.05). Conclusion: Short-term GFD reduced WC and improved glycemic control and Triglyceride level in subjects with the metabolic syndrome.

Keywords: Gluten free diet; metabolic syndrome; obesity.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Blood Glucose / physiology
  • Blood Pressure / physiology
  • Body Mass Index
  • Cholesterol, LDL / blood
  • Diet, Gluten-Free / methods
  • Female
  • Humans
  • Insulin / blood
  • Insulin Resistance / physiology
  • Male
  • Metabolic Syndrome / blood*
  • Metabolic Syndrome / physiopathology*
  • Middle Aged
  • Obesity / blood
  • Obesity / physiopathology
  • Triglycerides / blood
  • Waist Circumference / physiology

Substances

  • Biomarkers
  • Blood Glucose
  • Cholesterol, LDL
  • Insulin
  • Triglycerides